DDIAS Knockout Cell Line (Hela)

The choice depends on the experimental question. DDIAS (DNA damage-induced apoptosis suppressor, also designated NOXIN/C11orf82) has been characterized as an anti-apoptotic factor with emerging roles in cancer biology. The Knockout line is appropriate for asking whether DDIAS is required for predicted activities — DDIAS has been characterized as a DNA damage-induced anti-apoptotic factor that contributes to chemotherapy resistance in some cancer contexts. Overexpression is useful for studying DDIAS gain-of-function effects. For cancer biology research, the EDITGENE DDIAS Knockout in HeLa provides a clean genetic background for characterizing DDIAS-specific functions in apoptosis and chemotherapy response. Rescue with wild-type DDIAS is the standard specificity control. The knockout is valuable for studying DDIAS biology, chemotherapy resistance mechanisms, and emerging DDIAS-related cancer therapeutic strategies.

Primary applications: • Apoptosis sensitivity: DNA damage-induced apoptosis (cisplatin, etoposide, doxorubicin) sensitivity assays in DDIAS-null cells. • Chemotherapy resistance: in heterologous cancer-relevant contexts, assessment of DDIAS-mediated chemoresistance mechanisms. • Discovery proteomics: interactome analysis in DDIAS-null versus rescued cells. • Substrate phosphorylation: phosphoproteomics in DDIAS-null cells to identify candidate DDIAS-dependent signaling events. EDITGENE recommends this model for researchers investigating DDIAS-mediated apoptosis resistance and emerging DDIAS-related cancer biology.

Yes. DDIAS rescue experiments require attention to less-characterized protein architecture: • Construct design: use a codon-modified DDIAS sequence with a small C-terminal tag (FLAG, HA). DDIAS architecture is partially characterized — preserve protein integrity. • Discovery-oriented rescue: parallel wild-type rescue during phenotypic characterization distinguishes DDIAS-dependent phenotypes. • Functional readout: rescue should restore DDIAS-dependent apoptosis suppression and chemotherapy resistance. HeLa transduces efficiently with lentivirus and supports stable rescue line generation.